A Retrospective Analysis of Clinical Outcome and Predictive Factors for Responders with Knee Osteoarthritis to a Single Injection of Leukocyte-Poor Platelet-Rich Plasma
Although various platelet-rich plasma (PRP) kits are commercially available, the efficacy of these kits for knee osteoarthritis (KOA) has not been fully investigated. This study aimed to investigate the short-term results of leukocyte-poor PRP (LP-PRP) and the factors that contribute to its efficacy...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f2f502971cf84134a9d1cbfba74ad638 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f2f502971cf84134a9d1cbfba74ad638 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f2f502971cf84134a9d1cbfba74ad6382021-11-11T17:44:31ZA Retrospective Analysis of Clinical Outcome and Predictive Factors for Responders with Knee Osteoarthritis to a Single Injection of Leukocyte-Poor Platelet-Rich Plasma10.3390/jcm102151212077-0383https://doaj.org/article/f2f502971cf84134a9d1cbfba74ad6382021-10-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/21/5121https://doaj.org/toc/2077-0383Although various platelet-rich plasma (PRP) kits are commercially available, the efficacy of these kits for knee osteoarthritis (KOA) has not been fully investigated. This study aimed to investigate the short-term results of leukocyte-poor PRP (LP-PRP) and the factors that contribute to its efficacy. We retrospectively reviewed 124 patients with KOA who were treated with LP-PRP. White blood cell (WBC) and platelet counts in the whole blood and the LP-PRP were measured. KOA severity was assessed using radiography. Clinical evaluation was performed both prior to injection and after an average of 3.3 weeks after the injection using the Japanese Knee Osteoarthritis Measure (JKOM). Responders were defined based on the JKOM. The contributing factors for responders were examined using a multivariate logistic analysis. The responder rate was 58.1% and the contributing factors for responders were a higher visual analog scale score before injection, WBC count in whole blood, and platelet concentration ratio of LP-PRP. The LP-PRP improved the clinical scores in the short term. Certain patient characteristics before injection and the concentration ratio of LP-PRP may be predictors of its efficacy; these may provide clues for elucidating which components of LP-PRP act on KOA pathologies.Naoya KikuchiTomokazu YoshiokaNorihito AraiHisashi SugayaKojiro HyodoYu TaniguchiKosuke OkunoAkihiro KanamoriMasashi YamazakiMDPI AGarticleplasma rich in growth factorplatelet-rich plasmaknee osteoarthritisMedicineRENJournal of Clinical Medicine, Vol 10, Iss 5121, p 5121 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
plasma rich in growth factor platelet-rich plasma knee osteoarthritis Medicine R |
spellingShingle |
plasma rich in growth factor platelet-rich plasma knee osteoarthritis Medicine R Naoya Kikuchi Tomokazu Yoshioka Norihito Arai Hisashi Sugaya Kojiro Hyodo Yu Taniguchi Kosuke Okuno Akihiro Kanamori Masashi Yamazaki A Retrospective Analysis of Clinical Outcome and Predictive Factors for Responders with Knee Osteoarthritis to a Single Injection of Leukocyte-Poor Platelet-Rich Plasma |
description |
Although various platelet-rich plasma (PRP) kits are commercially available, the efficacy of these kits for knee osteoarthritis (KOA) has not been fully investigated. This study aimed to investigate the short-term results of leukocyte-poor PRP (LP-PRP) and the factors that contribute to its efficacy. We retrospectively reviewed 124 patients with KOA who were treated with LP-PRP. White blood cell (WBC) and platelet counts in the whole blood and the LP-PRP were measured. KOA severity was assessed using radiography. Clinical evaluation was performed both prior to injection and after an average of 3.3 weeks after the injection using the Japanese Knee Osteoarthritis Measure (JKOM). Responders were defined based on the JKOM. The contributing factors for responders were examined using a multivariate logistic analysis. The responder rate was 58.1% and the contributing factors for responders were a higher visual analog scale score before injection, WBC count in whole blood, and platelet concentration ratio of LP-PRP. The LP-PRP improved the clinical scores in the short term. Certain patient characteristics before injection and the concentration ratio of LP-PRP may be predictors of its efficacy; these may provide clues for elucidating which components of LP-PRP act on KOA pathologies. |
format |
article |
author |
Naoya Kikuchi Tomokazu Yoshioka Norihito Arai Hisashi Sugaya Kojiro Hyodo Yu Taniguchi Kosuke Okuno Akihiro Kanamori Masashi Yamazaki |
author_facet |
Naoya Kikuchi Tomokazu Yoshioka Norihito Arai Hisashi Sugaya Kojiro Hyodo Yu Taniguchi Kosuke Okuno Akihiro Kanamori Masashi Yamazaki |
author_sort |
Naoya Kikuchi |
title |
A Retrospective Analysis of Clinical Outcome and Predictive Factors for Responders with Knee Osteoarthritis to a Single Injection of Leukocyte-Poor Platelet-Rich Plasma |
title_short |
A Retrospective Analysis of Clinical Outcome and Predictive Factors for Responders with Knee Osteoarthritis to a Single Injection of Leukocyte-Poor Platelet-Rich Plasma |
title_full |
A Retrospective Analysis of Clinical Outcome and Predictive Factors for Responders with Knee Osteoarthritis to a Single Injection of Leukocyte-Poor Platelet-Rich Plasma |
title_fullStr |
A Retrospective Analysis of Clinical Outcome and Predictive Factors for Responders with Knee Osteoarthritis to a Single Injection of Leukocyte-Poor Platelet-Rich Plasma |
title_full_unstemmed |
A Retrospective Analysis of Clinical Outcome and Predictive Factors for Responders with Knee Osteoarthritis to a Single Injection of Leukocyte-Poor Platelet-Rich Plasma |
title_sort |
retrospective analysis of clinical outcome and predictive factors for responders with knee osteoarthritis to a single injection of leukocyte-poor platelet-rich plasma |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/f2f502971cf84134a9d1cbfba74ad638 |
work_keys_str_mv |
AT naoyakikuchi aretrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma AT tomokazuyoshioka aretrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma AT norihitoarai aretrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma AT hisashisugaya aretrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma AT kojirohyodo aretrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma AT yutaniguchi aretrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma AT kosukeokuno aretrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma AT akihirokanamori aretrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma AT masashiyamazaki aretrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma AT naoyakikuchi retrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma AT tomokazuyoshioka retrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma AT norihitoarai retrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma AT hisashisugaya retrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma AT kojirohyodo retrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma AT yutaniguchi retrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma AT kosukeokuno retrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma AT akihirokanamori retrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma AT masashiyamazaki retrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma |
_version_ |
1718432036372348928 |